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The dynamic organization of fungal acetyl-CoA
carboxylase
Moritz Hunkeler1,*, Edward Stuttfeld1,*, Anna Hagmann1, Stefan Imseng1 & Timm Maier1
Acetyl-CoA carboxylases (ACCs) catalyse the committed step in fatty-acid biosynthesis: the
ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA. They are important regulatory
hubs for metabolic control and relevant drug targets for the treatment of the metabolic
syndrome and cancer. Eukaryotic ACCs are single-chain multienzymes characterized by a
large, non-catalytic central domain (CD), whose role in ACC regulation remains poorly
characterized. Here we report the crystal structure of the yeast ACC CD, revealing a unique
four-domain organization. A regulatory loop, which is phosphorylated at the key functional
phosphorylation site of fungal ACC, wedges into a crevice between two domains of CD.
Combining the yeast CD structure with intermediate and low-resolution data of larger
fragments up to intact ACCs provides a comprehensive characterization of the dynamic
fungal ACC architecture. In contrast to related carboxylases, large-scale conformational
changes are required for substrate turnover, and are mediated by the CD under
phosphorylation control.
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B
iotin-dependent acetyl-CoA carboxylases (ACCs) are
essential enzymes that catalyse the ATP-dependent
carboxylation of acetyl-CoA to malonyl-CoA. This
reaction provides the committed activated substrate for the
biosynthesis of fatty acids via fatty-acid synthase1,2. By catalysing
this rate-limiting step in fatty-acid biosynthesis, ACC plays a key
role in anabolic metabolism. ACC inhibition and knock-out
studies show the potential of targeting ACC for treatment of
the metabolic syndrome3–5. Furthermore, elevated ACC activity
is observed in malignant tumours6,7. A direct link between ACC
and cancer is provided by cancer-associated mutations in the
breast cancer susceptibility gene 1 (BRCA1), which relieve
inhibitory interactions of BRCA1 with ACC8,9. Thus, ACC is a
relevant drug target for type 2 diabetes and cancer10,11. Microbial
ACCs are also the principal target of antifungal and antibiotic
compounds, such as Soraphen A12–14.
The principal functional protein components of ACCs have
been described already in the late 1960s for Escherichia coli
(E. coli) ACC15,16: Biotin carboxylase (BC) catalyses the
ATP-dependent carboxylation of a biotin moiety, which is
covalently linked to the biotin carboxyl carrier protein (BCCP).
Carboxyltransferase (CT) transfers the activated carboxyl group
from carboxybiotin to acetyl-CoA to yield malonyl-CoA.
Prokaryotic ACCs are transient assemblies of individual BC,
CT and BCCP subunits17. Eukaryotic ACCs, instead, are
multienzymes, which integrate all functional components into a
single polypeptide chain of B2,300 amino acids2. Human
ACC occurs in two closely related isoforms, ACC1 and 2,
located in the cytosol and at the outer mitochondrial membrane,
respectively18,19. In addition to the canonical ACC components,
eukaryotic ACCs contain two non-catalytic regions, the large
central domain (CD) and the BC–CT interaction domain (BT).
The CD comprises one-third of the protein and is a unique
feature of eukaryotic ACCs without homologues in other
proteins. The function of this domain remains poorly
characterized, although phosphorylation of several serine
residues in the CD regulates ACC activity20–22. The BT domain
has been visualized in bacterial carboxylases, where it mediates
contacts between a- and b-subunits23,24.
Structural studies on the functional architecture of intact ACCs
have been hindered by their huge size and pronounced dynamics,
as well as the transient assembly mode of bacterial ACCs.
However, crystal structures of individual components or
domains from prokaryotic and eukaryotic ACCs, respectively,
have been solved25–29. The structure determination of the
holoenzymes of bacterial biotin-dependent carboxylases, which
lack the characteristic CD, such as the pyruvate carboxylase
(PC)30, propionyl-CoA carboxylase23, 3-methyl-crotonyl-CoA
carboxylase24 and a long-chain acyl-CoA carboxylase31 revealed
strikingly divergent architectures despite a general conservation
of all functional components. In these structures, the BC and CT
active sites are at distances between 40 and 80Å, such that
substrate transfer could be mediated solely by the mobility of the
flexibly tethered BCCP.
Human ACC1 is regulated allosterically, via specific
protein–protein interactions, and by reversible phosphorylation.
Dynamic polymerization of human ACC1 is linked to increased
activity and is regulated allosterically by the activator citrate
and the inhibitor palmitate20,21, or by binding of the small
protein MIG-12 (ref. 32). Human ACC1 is further regulated by
specific phosphorylation-dependent binding of BRCA1 to
Ser1263 in the CD. BRCA1 binds only to the phosphorylated
form of ACC1 and prevents ACC activation by phosphatase-
mediated dephosphorylation9,33. Furthermore, phosphorylation
by AMP-activated protein kinase (AMPK) and cAMP-dependent
protein kinase (PKA) leads to a decrease in ACC1 activity. AMPK
phosphorylates ACC1 in vitro at Ser80, Ser1201 and Ser1216 and
PKA at Ser78 and Ser1201. However, regulatory effects on
ACC1 activity are mainly mediated by phosphorylation of
Ser80 and Ser1201 (refs 34,35). Phosphorylated Ser80, which is
highly conserved only in higher eukaryotes, presumably binds
into the Soraphen A-binding pocket36. The regulatory Ser1201
shows only moderate conservation across higher eukaryotes,
while the phosphorylated Ser1216 is highly conserved across all
eukaryotes. However, no effect of Ser1216 phosphorylation on
ACC activity has been reported in higher eukaryotes.
For fungal ACC, neither spontaneous nor inducible
polymerization has been detected despite considerable sequence
conservation to human ACC1. The BRCA1-interacting
phosphoserine position is not conserved in fungal ACC, and no
other phospho-dependent protein–protein interactions of fungal
ACC have been described. In yeast ACC, phosphorylation
sites have been identified at Ser2, Ser735, Ser1148, Ser1157
and Ser1162 (ref. 37). Of these, only Ser1157 is highly conserved
in fungal ACC and aligns to Ser1216 in human ACC1. Its
phosphorylation by the AMPK homologue SNF1 results in
strongly reduced ACC activity22,38.
Despite the outstanding relevance of ACC in primary
metabolism and disease, the dynamic organization and regulation
of the giant eukaryotic, and in particular fungal ACC,
remain poorly characterized. Here we provide the structure of
Saccharomyces cerevisiae (Sce) ACC CD, intermediate- and
low-resolution structures of human (Hsa) ACC CD and larger
fragments of fungal ACC from Chaetomium thermophilum
(Cth; Fig. 1a). Integrating these data with small-angle X-ray
scattering (SAXS) and electron microscopy (EM) observations
yield a comprehensive representation of the dynamic structure
and regulation of fungal ACC.
Results
The organization of the yeast ACC CD. First, we focused on
structure determination of the 82-kDa CD. The crystal structure
of the CD of SceACC (SceCD) was determined at 3.0 Å resolution
by experimental phasing and refined to Rwork/Rfree¼ 0.20/0.24
(Table 1). The overall extent of the SceCD is 70 by 75Å (Fig. 1b
and Supplementary Fig. 1a,b), and the attachment points of the
N-terminal 26-residue linker to the BCCP domain and the
C-terminal CT domain are separated by 46Å (the N- and C
termini are indicated with spheres in Fig. 1b). SceCD comprises
four distinct domains, an N-terminal a-helical domain (CDN),
and a central four-helix bundle linker domain (CDL), followed by
two a–b-fold C-terminal domains (CDC1/CDC2). CDN adopts a
letter C shape, where one of the ends is a regular four-helix
bundle (Na3-6), the other end is a helical hairpin (Na8,9) and the
bridging region comprises six helices (Na1,2,7,10–12). CDL is
composed of a small, irregular four-helix bundle (La1–4)
and tightly interacts with the open face of CDC1 via an
interface of 1,300Å2 involving helices La3 and La4. CDL does not
interact with CDN apart from the covalent linkage and forms only
a small contact to CDC2 via a loop between La2/a3 and the
N-terminal end of La1, with an interface area of 400Å2.
CDC1/CDC2 share a common fold; they are composed of
six-stranded b-sheets flanked on one side by two long, bent
helices inserted between strands b3/b4 and b4/b5. CDC2 is
extended at its C terminus by an additional b-strand and an
irregular b-hairpin. On the basis of a root mean square
deviation of main chain atom positions of 2.2 Å, CDC1/CDC2 are
structurally more closely related to each other than to any other
protein (Fig. 1c); they may thus have evolved by duplication.
Close structural homologues could not be found for the CDN or
the CDC domains.
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Figure 1 | The phosphorylated central domain of yeast ACC. (a) Schematic overview of the domain organization of eukaryotic ACCs. Crystallized
constructs are indicated. (b) Cartoon representation of the SceCD crystal structure. CDN is linked by a four-helix bundle (CDL) to two a–b-fold
domains (CDC1 and CDC2). The regulatory loop is shown as bold cartoon, and the phosphorylated Ser1157 is marked by a red triangle. The N- and C termini
are indicated by spheres. (c) Superposition of CDC1 and CDC2 reveals highly conserved folds. (d) The regulatory loop with the phosphorylated
Ser1157 is bound into a crevice between CDC1 and CDC2, the conserved residues Arg1173 and Arg1260 coordinate the phosphoryl-group. (e) Structural
overview of HsaBT-CD. The attachment points to the N-terminal BCCP domain and the C-terminal CT domain are indicated with spheres. All colourings
are according to scheme a.
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A regulatory loop mediates interdomain interactions. To define
the functional state of insect-cell-expressed ACC variants, we
employed mass spectrometry (MS) for phosphorylation site
detection. In insect-cell-expressed full-length SceACC, the
highly conserved Ser1157 is the only fully occupied phosphor-
ylation site with functional relevance in S. cerevisiae. Additional
phosphorylation was detected for Ser2101 and Tyr2179; however,
these sites are neither conserved across fungal ACC nor natively
phosphorylated in yeast. MS analysis of dissolved crystals
confirmed the phosphorylated state of Ser1157 also in SceCD
crystals. The SceCD structure thus authentically represents
the state of SceACC, where the enzyme is inhibited by
SNF1-dependent phosphorylation.
In the SceCD crystal structure, the phosphorylated Ser1157
resides in a regulatory 36-amino-acid loop between strands b2
and b3 of CDC1 (Fig. 1b,d), which contains two additional
less-conserved phosphorylation sites (Ser1148 and Ser1162)
confirmed in yeast39, but not occupied here. This regulatory
loop wedges between the CDC1 and CDC2 domains and provides
the largest contribution to the interdomain interface. The
N-terminal region of the regulatory loop also directly contacts
the C-terminal region of CDC2 leading into CT. Phosphoserine
1157 is tightly bound by two highly conserved arginines (Arg1173
and Arg1260) of CDC1 (Fig. 1d). Already the binding of
phosphorylated Ser1157 apparently stabilizes the regulatory
loop conformation; the accessory phosphorylation sites Ser1148
and Ser1162 in the same loop may further modulate the
strength of interaction between the regulatory loop and the
CDC1 and CDC2 domains. Phosphorylation of the regulatory loop
thus determines interdomain interactions of CDC1 and CDC2,
suggesting that it may exert its regulatory function by modifying
the overall structure and dynamics of the CD.
The functional role of Ser1157 was confirmed by an activity
assay based on the incorporation of radioactive carbonate
into acid non-volatile material40. Phosphorylated SceACC
shows only residual activity (kcat¼ 0.4±0.2 s 1, s.d. based on
five replicate measurements), which increases 16-fold
(kcat¼ 6.5±0.3 s 1) after dephosphorylation with l protein
phosphatase. The values obtained for dephosphorylated SceACC
are comparable to earlier measurements of non-phosphorylated
yeast ACC expressed in E. coli41.
The variable CD is conserved between yeast and human. To
compare the organization of fungal and human ACC CD, we
determined the structure of a human ACC1 fragment that
comprises the BT and CD domains (HsaBT-CD), but lacks the
mobile BCCP in between (Fig. 1a). An experimentally phased
map was obtained at 3.7 Å resolution for a cadmium-derivatized
crystal and was interpreted by a poly-alanine model (Fig. 1e and
Table 1). Each of the four CD domains in HsaBT-CD individually
resembles the corresponding SceCD domain; however, human
and yeast CDs exhibit distinct overall structures. In agreement
with their tight interaction in SceCD, the relative spatial
arrangement of CDL and CDC1 is preserved in HsaBT-CD, but
the human CDL/CDC1 didomain is tilted by 30 based on a
superposition of human and yeast CDC2 (Supplementary Fig. 1c).
As a result, the N terminus of CDL at helix La1, which connects
to CDN, is shifted by 12Å. Remarkably, CDN of HsaBT-CD
adopts a completely different orientation compared with SceCD.
Table 1 | Crystallographic data collection and refinement statistics.
SceCD SceCD Thimerosal SceCD Eu HsaBT-CD HsaBT-CD Cd2þ CthCD-
CTCter1
CthCD-
CTCter2
CthCD-CT CthDBCCP
Data collection
Space group P43212 P43212 P43212 I4122 I4122 P212121 P212121 P31212 P6422
Cell dimensions
a, b, c (Å) 110.86,
110.86,
131.12
111.22,
111.22,
131.49
108.65,
108.65,
127.36
267.27,
267.27,
210.61
267.67,
267.67,
210.46
97.66,
165.34,
219.23
100.17,
153.45,
249,24
295.02,
295.02,
189.52
462.20,
462.20,
204.64
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 120 90, 90, 120
Resolution* (Å) 3.0 3.4 4.0 3.7 4.1 3.6 4.5 7.2 8.4
RMerge
w 18.2 (389.6) 20.5 (306.1) 40.6 (327.0) 7.5 (400.9) 15 (730.5) 14.5 (384.5) 27.4 (225.6) 5.6 (302.6) 29.4 (381.7)
CC ½*,w 100 (58.3) 99.9 (42.6) 99.9 (48.5) 100 (59.4) 99.8 (73.2) 99.9 (50.9) 99.5 (46.7) 100 (33.3) 99.7 (35)
I/sIw 24.68 (1.46) 7.99 (0.89) 17.92 (1.85) 21.24 (1.07) 16.53 (1.41) 10.61 (0.97) 6.35 (1.00) 18.95 (0.92) 9.05 (0.9)
Completenessw 99.9 (99.9) 99.6 (100) 99.7 (96.8) 99.8 (99.1) 99.8 (99.7) 99.7 (99.9) 99.4 (98.6) 99.6 (100) 99.1 (99.9)
Redundancyw 39.1 (39.8) 12.1 (14.3) 81.6 (65.2) 13.7 (13.7) 20.9 (19.1) 12.7 (13.5) 6.1 (6.5) 9.9 (10.4) 18.5 (18.2)
Refinement
Resolution* (Å) 46.4–3.0 84.5–3.7 49.2–3.6 49.1–4.5 49.9–7.2 50.0–8.4
Reflections 16,928 — — 40,647 — 41,799 23,340 14,046 12,111
Rwork/Rfree 0.20/0.24 — — 0.35/0.38
z — 0.20/0.24 0.24/0.24 0.23/0.25 0.30/0.32
Number of atoms
Protein 5,465 6,925 16,592 16,405 22,543 22,445
Waters 43 — — — — — — — —
Ligand/ion 7 — — 5 — — — — —
B-factors
Protein 130 158 226 275 272 250
Waters 84 — — — — — — — —
Ligand/ion 90 — — 189 — — — — —
R.m.s.d.
RMS (angles, ) 0.97 — — 0.83 — 1.07 1.11 1.15 1.01
RMS (bonds, Å) 0.01 — — 0.01 — 0.01 0.01 0.01 0.01
*Resolution cutoffs determined based on internal correlation significant at the 0.1% level as calculated by XDS.
wHighest-resolution shell is shown in parentheses.
zModelled only as poly-alanine.
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With CDL/CDC1 superposed, CDN in HsaBT-CD is rotated by
160 around a hinge at the connection of CDN/CDL
(Supplementary Fig. 1d). This rotation displaces the N terminus
of CDN in HsaBT-CD by 51Å compared with SceCD, resulting in
a separation of the attachment points of the N-terminal linker
to the BCCP domain and the C-terminal CT domain by 67Å
(the attachment points are indicated with spheres in Fig. 1e).
The BT domain of HsaBT-CD consists of a helix that is
surrounded at its N terminus by an antiparallel eight-stranded
b-barrel. It resembles the BT of propionyl-CoA carboxylase23;
only the four C-terminal strands of the b-barrel are slightly tilted.
On the basis of MS analysis of insect-cell-expressed human full-
length ACC, Ser80 shows the highest degree of phosphorylation
(90%). Ser29 and Ser1263, implicated in insulin-dependent
phosphorylation and BRCA1 binding, respectively, are phosphory-
lated at intermediate levels (40%). The highly conserved Ser1216
(corresponding to S. cerevisiae Ser1157), as well as Ser1201, both in
the regulatory loop discussed above, are not phosphorylated.
However, residual phosphorylation levels were detected for
Ser1204 (7%) and Ser1218 (7%) in the same loop. MS analysis of
the HsaBT-CD crystallization sample reveals partial proteolytic
digestion of the regulatory loop. Accordingly, most of this loop is
not represented in the HsaBT-CD crystal structure. The absence of
the regulatory loop might be linked to the less-restrained interface
of CDL/CDC1 and CDC2 and altered relative orientations of these
domains. Besides the regulatory loop, also the phosphopeptide
target region for BRCA1 interaction is not resolved presumably
because of pronounced flexibility.
At the level of isolated yeast and human CD, the structural
analysis indicates the presence of at least two hinges, one with
large-scale flexibility at the CDN/CDL connection, and one with
tunable plasticity between CDL/CDC1 and CDC2, plausibly
affected by phosphorylation in the regulatory loop region.
The integration of CD into the fungal ACC multienzyme. To
further obtain insights into the functional architecture of fungal
ACC, we characterized larger multidomain fragments up to the
intact enzymes. Using molecular replacement based on fungal
ACC CD and CT models, we obtained structures of a variant
comprising CthCT and CDC1/CDC2 in two crystal forms at
resolutions of 3.6 and 4.5 Å (CthCD-CTCter1/2), respectively, as
well as of a CthCT linked to the entire CD at 7.2 Å resolution
(CthCD-CT; Figs 1a and 2, Table 1). No crystals diffracting to
sufficient resolution were obtained for larger BC-containing
fragments, or for full-length Cth or SceACC. To improve
crystallizability, we generated DBCCP variants of full-length
ACC, which, based on SAXS analysis, preserve properties of
intact ACC (Supplementary Table 1 and Supplementary Fig. 2a–
c). For CthDBCCP, crystals diffracting to 8.4 Å resolution were
obtained. However, molecular replacement did not reveal a
unique positioning of the BC domain. Owing to the limited
resolution the discussion of structures of CthCD-CT and
CthDBCCP is restricted to the analysis of domain localization.
Still, these structures contribute considerably to the visualization
of an intrinsically dynamic fungal ACC.
In all these crystal structures, the CT domains build a canonical
head-to-tail dimer29, with active sites formed by contributions
from both protomers (Fig. 2 and Supplementary Fig. 3a).
The connection of CD and CT is provided by a 10-residue
peptide stretch, which links the N terminus of CT to the irregular
b-hairpin/b-strand extension of CDC2 (Supplementary Fig. 3b).
The connecting region is remarkably similar in isolated CD and
CthCD-CTCter structures, indicating inherent conformational
stability. CD/CT contacts are only formed in direct vicinity of
the covalent linkage and involve the b-hairpin extension of CDC2
as well as the loop between strands b2/b3 of the CT N-lobe,
which contains a conserved RxxGxN motif. The neighbouring
loop on the CT side (between CT b1/b2) is displaced by 2.5 Å
compared to isolated CT structures (Supplementary Fig. 3c). On
the basis of an interface area of B600Å2 and its edge-to-edge
connection characteristics, the interface between CT and CD
might be classified as conformationally variable. Indeed,
the comparison of the positioning of eight instances of the
C-terminal part of CD relative to CT in crystal structures
determined here, reveals flexible interdomain linking (Fig. 3a).
The CDC2/CT interface acts as a true hinge with observed
rotation up to 16, which results in a translocation of the distal
end of CDC2 by 8Å.
The interface between CDC2 and CDL/CDC1, which is mediated
by the phosphorylated regulatory loop in the SceCD structure, is
less variable than the CD–CT junction, and permits only limited
rotation and tilting (Fig. 3b). Analysis of the impact of
phosphorylation on the interface between CDC2 and CDL/CDC1
in CthACC variant structures is precluded by the limited
crystallographic resolution. However, MS analysis of CthCD-CT
and CthDBCCP constructs revealed between 60 and 70%
phosphorylation of Ser1170 (corresponding to SceACC Ser1157).
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Figure 2 | Architecture of the CD–CT core of fungal ACC. Cartoon
representation of crystal structures of multidomain constructs of CthACC.
One protomer is shown in colour and one in grey. Individual domains are
labelled; the active site of CT and the position of the conserved regulatory
phosphoserine site based on SceCD are indicated by an asterisk and a
triangle, respectively.
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The CDN domain positioning relative to CDL/CDC1 is highly
variable with three main orientations observed in the structures of
SceCD and the larger CthACC fragments: CDN tilts, resulting in a
displacement of its N terminus by 23Å (Fig. 4a, observed in both
protomers of CthCD-CT and one protomer of CthDBCCP,
denoted as CthCD-CT1/2 and CthDBCCP1, respectively). In
addition, CDN can rotate around hinges in the connection
between CDN/CDL by 70 (Fig. 4b, observed in the second
protomer of CthDBCCP, denoted as CthDBCCP2) and 160
(Fig. 4c, observed in SceCD) leading to displacement of the
anchor site for the BCCP linker by up to 33 and 40Å,
respectively.
Conformational variability in the CD thus contributes
considerably to variations in the spacing between the BC and
CT domains, and may extend to distance variations beyond the
mobility range of the flexibly tethered BCCP. On the basis of the
occurrence of related conformational changes between fungal and
human ACC fragments, the observed set of conformations may
well represent general states present in all eukaryotic ACCs.
Large-scale conformational variability of fungal ACC. To
obtain a comprehensive view of fungal ACC dynamics in
solution, we employed SAXS and EM. SAXS analysis of CthACC
agrees with a dimeric state and an elongated shape with a
maximum extent of 350Å (Supplementary Table 1). The smooth
appearance of scattering curves and derived distance distributions
might indicate substantial interdomain flexibility42
(Supplementary Fig. 2a–c). Direct observation of individual full-
length CthACC particles, according to MS results predominantly
in a phosphorylated low-activity state, in negative stain EM
reveals a large set of conformations from rod-like extended to
U-shaped particles. Class averages, obtained by maximum-
likelihood-based two-dimensional (2D) classification, are
focused on the dimeric CT domain and the full BC–BCCP–CD
domain of only one protomer, due to the non-coordinated
motions of the lateral BC/CD regions relative to the CT dimer.
They identify the connections between CDN/CDL and between
CDC2/CT as major contributors to conformational heterogeneity
(Supplementary Fig. 4a,b). The flexibility in the CDC2/CT hinge
appears substantially larger than the variations observed in the set
of crystal structures. The BC domain is not completely
disordered, but laterally attached to BT/CDN in a generally
conserved position, albeit with increased flexibility. Surprisingly,
in both the linear and U-shaped conformations, the approximate
distances between the BC and CT active sites would remain larger
than 110Å. These observed distances are considerably larger than
in static structures of any other related biotin-dependent
carboxylase. Furthermore, based on an average length of the
BCCP–CD linker in fungal ACC of 26 amino acids, mobility of
the BCCP alone would not be sufficient to bridge the active sites
of BC and CT. Consequently, increased flexibility or additional
modes of conformational changes may be required for productive
catalysis. The most relevant candidate site for mediating such
additional flexibility and permitting an extended set of
conformations is the CDC1/CDC2 interface, which is rigidified
by the Ser1157-phosphorylated regulatory loop, as depicted in the
SceCD crystal structure.
Discussion
Altogether, the architecture of fungal ACC is based on the central
dimeric CT domain (Fig. 4d). The CD consists of four distinct
subdomains and acts as a tether from the CT to the mobile BCCP
and an oriented BC domain. The CD has no direct role in
substrate recognition or catalysis but contributes to the regulation
of all eukaryotic ACCs. In higher eukaryotic ACCs, regulation via
phosphorylation is achieved by combining the effects of
phosphorylation at Ser80, Ser1201 and Ser1263. In fungal ACC,
however, Ser1157 in the regulatory loop of the CD is the only
phosphorylation site that has been demonstrated to be both
phosphorylated in vivo and involved in the regulation of
ACC activity. In its phosphorylated state, the regulatory loop
containing Ser1157 wedges between CDC1/CDC2 and presumably
limits the conformational freedom at this interdomain interface.
However, flexibility at this hinge may be required for full ACC
activity, as the distances between the BCCP anchor points and the
active sites of BC and CT observed here are such large that
mobility of the BCCP alone is not sufficient for substrate transfer.
The current data thus suggest that regulation of fungal ACC is
mediated by controlling the dynamics of the unique CD, rather
than directly affecting catalytic turnover at the active sites of BC
and CT. A comparison between fungal and human ACC will help
to further discriminate mechanistic differences that contribute to
the extended control and polymerization of human ACC.
Most recently, a crystal structure of near full-length
non-phosphorylated ACC from S. cerevisae (lacking only
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Figure 3 | Variability of the connections of CDC2 to CTand CDC1 in fungal
ACC. (a) Hinge properties of the CDC2–CT connection analysed by a CT-
based superposition of eight instances of the CDC2-CT segment. For clarity,
only one protomer of CthCD-CTCter1 is shown in full colour as reference. For
other instances, CDC2 domains are shown in transparent tube
representation with only one helix each highlighted. The range of hinge
bending is indicated and the connection points between CDC2 and CT
(blue) as well as between CDC1 and CDC2 (green and grey) are marked as
spheres. (b) The interdomain interface of CDC1 and CDC2 exhibits only
limited plasticity. Representation as in a, but the CDC1 and CDC2 are
superposed based on CDC2. One protomer of CthDBCCP is shown in colour,
the CDL domains are omitted for clarity and the position of the
phosphorylated serine based on SceCD is indicated with a red triangle. The
connection points from CDC1 to CDC2 and to CDL are represented by green
spheres.
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21 N-terminal amino acids, here denoted as flACC) was
published by Wei and Tong41. In flACC, the ACC dimer obeys
twofold symmetry and assembles in a triangular architecture with
dimeric BC domains (Supplementary Fig. 5a). In their study,
mutational data indicate a requirement for BC dimerization for
catalytic activity. The transition from the elongated open shape,
observed in our experiments, towards a compact triangular shape
is based on an intricate interplay of several hinge-bending
motions in the CD (Fig. 4d). Comparison of flACC with our
CthDBCCP structure reveals the CDC2/CT hinge as a major
contributor to conformational flexibility (Supplementary
Fig. 5b,c). In flACC, CDC2 rotates B120 with respect to the
CT domain. A second hinge can be identified between CDC1/
CDC2. On the basis of a superposition of CDC2, CDC1 of the
phosphorylated SceCD is rotated by 30 relative to CDC1 of the
non-phosphorylated flACC (Supplementary Fig. 5d), similar to
what we have observed for the non-phosphorylated HsaBT-CD
(Supplementary Fig. 1d). When inspecting all individual
protomer and fragment structures in their study, Wei and Tong
also identify the CDN/CDC1 connection as a highly flexible hinge,
in agreement with our observations.
The only bona fide regulatory phophorylation site of fungal
ACC in the regulatory loop is directly participating in
CDC1/CDC2 domain interactions and thus stabilizes the hinge
conformation. In flACC, the regulatory loop is mostly disordered,
illustrating the increased flexibility due to the absence of the
phosphoryl group. Only in three out of eight observed protomers
a short peptide stretch (including Ser1157) was modelled.
In those instances the Ser1157 residue is located at a distance
of 14–20Å away from the location of the phosphorylated serine
observed here, based on superposition of either CDC1 or CDC2.
Applying the conformation of the CDC1/CDC2 hinge observed in
SceCD on flACC leads to CDN sterically clashing with CDC2 and
BT/CDN clashing with CT (Supplementary Fig. 6a,b). Thus, in
accordance with the results presented here, phosphorylation of
Ser1157 in SceACC most likely limits flexibility in the CDC1/CDC2
hinge such that activation through BC dimerization is not
possible (Fig. 4d), which however does not exclude intermolecular
dimerization. In addition, EM micrographs of phosphorylated
and dephosphorylated SceACC display for both samples mainly
elongated and U-shaped conformations and reveal no apparent
differences in particle shape distributions (Supplementary Fig. 7).
This implicates that the triangular shape with dimeric BC
domains has a low population also in the active form, even
though a biasing influence of grid preparation cannot be excluded
completely.
Large-scale conformational variability has also been observed in
most other carrier protein-based multienzymes, including polyke-
tide43 and fatty-acid synthases (with the exception of fungal-type
fatty-acid synthases)44,45, non-ribosomal peptide synthetases46 and
the pyruvate dehydrogenase complexes47, although based on
completely different architectures. Together, this structural
information suggests that variable carrier protein tethering is not
sufficient for efficient substrate transfer and catalysis in any of
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Figure 4 | The conformational dynamics of fungal ACC. (a–c) Large-scale conformational variability of the CDN domain relative to the CDL/CDC1 domain.
CthCD-CT1 (in colour) serves as reference, the compared structures (as indicated, numbers after construct name differentiate between individual
protomers) are shown in grey. Domains other than CDN and CDL/CDC1 are omitted for clarity. The domains are labelled and the distances between the N
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these systems. The determination of a set of crystal structures of
SceACC in two states, unphosphorylated41 and phosphorylated at
the major regulatory site Ser1157, provides a unique depiction of
multienzyme regulation by post-translational modification
(Fig. 4d). The phosphorylated regulatory loop binds to an
allosteric site at the interface of two non-catalytic domains and
restricts conformational freedom at several hinges in the dynamic
ACC. It disfavours the adoption of a rare, compact conformation,
in which intramolecular dimerization of the BC domains41 results
in catalytic turnover. The regulation of activity thus results from
restrained large-scale conformational dynamics rather than a direct
or indirect influence on active site structure. To our best
knowledge, ACC is the first multienzyme for which such a
phosphorylation-dependent mechanical control mechanism has
been visualized. However, the example of ACC now demonstrates
the possibility of regulating activity by controlled dynamics of non-
enzymatic linker regions also in other families of carrier-dependent
multienzymes. Understanding such structural and dynamic
constraints imposed by scaffolding and linking in carrier protein-
based multienzyme systems is a critical prerequisite for engineering
of efficient biosynthetic assembly lines.
Methods
Protein expression and purification. All proteins were expressed in the Bacu-
lovirus Expression Vector System. The MultiBac insect cell expression plasmid
pACEBACI (Geneva Biotech) was modified to host a GATEWAY (Life-
Technologies) cassette with an N-terminal 10xHis-tag, named pAB1GW-NH10
hereafter. Full-length HsaACC (Genebank accession #Q13085), SceACC
(#Q00955) and CthACC (#G0S3L5) were cloned into pAB1GW-NH10 using
GATEWAY according to the manufacturer’s manual. Truncated variants were
constructed by PCR amplification, digestion of the template DNA with DpnI,
phosphorylation of the PCR product and religation of the linear fragment to a
circular plasmid. The following constructs were used for this study: SceACC
(1–2,233), CthACC (1–2,297), CthDBCCP (1–2,297, D700–765), CthCD-CT
(788–2,297), CthCD-CTCter (1,114–2,297), SceCD (768–1,494) and HsaBT-CD
(622–1,584, D753–818). Bacmid and virus production was carried out according to
MultiBac instructions48. Baculovirus generation and amplification as well as
protein expression were performed in Sf21 cells (Expression Systems) in
Insect-Xpress medium (Lonza). The cells were harvested 68–96 h post infection by
centrifugation and stored at  80 C until being processed.
Cells were lysed by sonication and the lysate was cleared by ultracentrifugation.
Soluble protein was purified using Ni-NTA (Genscript) and size exclusion
chromatography (Superose 6, GE Healthcare). The affinity tag was removed by
tobacco etch virus (TEV) protease cleavage overnight at 4 C. TEV protease and
uncleaved protein were removed by orthogonal Ni-NTA purification before size
exclusion chromatography. SceACC, CthACC and CthDBCCP were further
purified by high-resolution anion exchange chromatography before size exclusion
chromatography. Purified SceCD, CthCD-CTCter, CthCD-CT, CthDBCCP, CthACC
and SceACC were concentrated to 10mgml 1 in 30mM 3-(N-morpholino)
propanesulfonic acid (MOPS) pH 7, 200mM ammonium sulfate, 5% glycerol and
10mM dithiothreitol. Purified HsaBT-CD was concentrated to 20mgml 1 in
20mM bicine pH 8.0, 200mM NaCl, 5% glycerol and 5mM tris(2-carboxyethyl)
phosphine (TCEP). Proteins were used directly or were stored at  80 C after
flash-freezing in liquid nitrogen.
Protein crystallization. All crystallization experiments were conducted using
sitting drop vapour diffusion. SceCD crystals were grown at 19 C by mixing
protein and reservoir solution (0.1M BisTrisPropane pH 6.5, 0.05–0.2M
di-sodium malonate, 20–30% polyethylene glycol (PEG) 3350, 10mM trimethy-
lamine or 2% benzamidine) in a 1:1 or 2:1 ratio. Crystals appeared after several
days and continued to grow for 20–200 days. Crystals were cryoprotected by short
incubation in mother liquor supplemented with 22% ethylene glycol and
flash-cooled in liquid nitrogen. For heavy metal derivatization the crystals
were incubated in stabilization solution supplemented with 1mM Thimerosal
or 10mM EuCl2, and then backsoaked for 15 s in stabilization solution without
heavy metal.
Initial crystals of HsaBT-CD grew in 0.1M Tris pH 8.5, 0.35M tri-potassium
citrate and 2–3.5% PEG10000 at 19 C. After several rounds of optimization,
good-quality diffraction crystals were obtained at 19 C in 0.1M MES pH 6,
0.25–0.35M tri-potassium citrate, 2–5% PEG10000 and 0.01–0.04M cadmium
chloride. The protein drop contained a 1:1 ratio of protein and reservoir solution.
Crystals grew immediately and stopped growing after 3 days. They were
dehydrated and cryoprotected in several steps in artificial mother liquor containing
incrementally increasing concentrations of tri-potassium citrate, PEG10000 and
ethylene glycol and then flash-cooled in liquid nitrogen. The final solution was
composed of 0.1M MES pH 6, 0.5 M tri-potassium citrate, 6.75% PEG10000,
0.01M cadmium chloride and 22% ethylene glycol.
CthCD-CTCter crystals were grown at 19 C by mixing protein and reservoir
solution (0.1M HEPES pH 7.5, 2–7% Tacsimate pH 7, 7.5–15% PEG monomethyl
ether 5000) in a 1:1 ratio. Crystals appeared after several days and continued to
grow for up to 2 weeks. Crystals were cryoprotected by short incubation in mother
liquor supplemented with 22% ethylene glycol.
CthCD-CT ACC crystals were grown at 19 C by mixing protein and reservoir
solution (0.1M Bicine pH 8.5–9.5, 4–8% PEG8000) in a 1:1 or 1:2 ratio. Crystals
grew 8– 10 days and were cryoprotected by short incubation in mother liquor
supplemented with 22% ethylene glycol before flash-cooling in liquid nitrogen.
CthDBCCP ACC crystals were grown at 19 C by mixing protein and reservoir
solution (0.1M Morpheus buffer 3 (Molecular Dimensions, MD2-100-102), 7–12%
Morpheus ethylene glycols mix (MD2-100-74), 8–12% PEG4000, 17–23% glycerol)
in a 1:1 or 1:2 ratio. Crystals grew up to 3 weeks and were cryoprotected in
reservoir solution before flash-cooling in liquid nitrogen.
Structure determination and analysis of phosphorylation. All X-ray diffraction
data were collected at beamlines X06SA (PXI) or X06DA (PXIII) at the Swiss Light
Source (SLS, Paul Scherrer Institute, Villigen, Switzerland) equipped with
PILATUS detectors. The wavelength of data collection was 1.000Å for native crystals,
and 1.527 and 1.907Å for crystals derivatized with europium and cadmium,
respectively. Raw data were processed using XDS49. Molecular replacement was
carried out using Phaser 2.5.7 and 2.6.0, density modification was performed using
Parrot50,51 and resolve, multicrystal averaging52 was carried out using phenix. All
model building procedures were conducted using Coot53 and figures were prepared
using PyMOL (Schro¨dinger LLC).
Diffraction of initial SceCD crystals in space group P43212 with unit cell
dimensions of a¼ b¼ 110.3Å and c¼ 131.7Å was limited to 3.5Å. The resolution
was improved to 3Å by addition of trimethylamine or benzamidine to the reservoir
solution without significant changes in unit cell dimensions. Crystals derivatized with
thimerosal and europium were used for initial SAD phase determination using the
SHELXC/D package54. Two mercury and four europium sites were located, and an
initial model was placed in the resulting maps. Since crystals derivatized with
europium were slightly non-isomorphous with a c axis length of 127Å, multicrystal
averaging was used for density modification and provided directly interpretable maps.
Iterative cycles of model building and refinement in Buster (version 2.10.2; Global
Phasing Ltd) converged at Rwork/Rfree of 0.20/0.24. The final model lacks the
disordered N terminus (amino acids 768–789), an extended loop in the CDC1 domain
(1,203–1,215), a short stretch (1,147–1,149) preceding the regulatory loop and the
two very C-terminal residues (1,493–1,494). On the basis of temperature factor
analysis, the start and end of the regulatory loop show higher disorder than the
region around the interacting phosphoserine 1157. MS analysis of dissolved crystals
detected quantitative phosphorylation of the regulatory Ser1157, as also found for
full-length SceACC, and additionally albeit with much lower occurrence,
phosphorylation of Ser790, Ser1137, Ser1148 and Ser1159. A modelled phosphoryl
position for Ser1159 could overlap with the one of Ser1157, and might be represented
in the crystal. For all other phosphorylation sites no difference density could be
observed, probably because of very low occupancy. PDBeFold55 was used to search
for structural homologues. The thresholds for lowest acceptable percentage of
matched secondary structure elements were 70% for the search query and 20%
for the result.
Initial HsaBT-CD crystals were obtained in space group I4122 with
a¼ b¼ 240.1 Å and c¼ 768.9Å and diffracted to 7.5 Å. Optimized and dehydrated
crystals also belonged to space group I4122 but with unit cell parameters
a¼ b¼ 267.3 Å and c¼ 210.6Å and diffracted to a resolution of 3.7 Å. Phase
information was obtained from SAD based on bound cadmium ions from the
crystallization condition. Six cadmium positions were located in a 4.0-Å resolution
data set at 1.9 Å wavelength using SHELXC/D54 via the HKL2MAP interface56.
Density modification and phasing based on this anomalous data set, a 3.7-Å
resolution data set at 1.0 Å wavelength and additional non-isomorphous
lower-resolution data sets led to a high-quality electron density map. At the
intermediate resolution obtained, the map was interpreted by a poly-alanine model,
which was guided by predicted secondary structure as well as sequence and
structural alignment with SceCD. The final model contains five cadmium ions and
refines using phenix52 against experimental data with Rwork/Rfree of 0.35/0.38, as
expected for a poly-alanine model. Two HsaBT-CD monomers are packed in the
asymmetric unit via the CDN and BT domains. Density on top of the b-barrel of
one BT most likely representing parts of the BT–CD linker guided the assignment
of this BT to its linked CD partner domain. This BT-to-CD assignment was further
supported by the analysis of an additional lower-resolution crystal form. Cadmium
ions were found to participate in crystal packing.
In HsaACC, phosphorylation at regulatory sites was detected as provided in the
main text. No phosphorylation was detected for other phosphosites previously
identified in large-scale phosphoproteomics studies, namely serines 5, 23, 25, 48,
53, 78, 488, 786, 1273 (refs 57–59).
Two different crystal forms were obtained for CthCD-CTCter (denoted as
CthCD-CTCter1 and CthCD-CTCter2), diffracting to 3.6 and 4.5 Å. Both forms
packed in space group P212121 with unit cell constants of a¼ 97.7 Å, b¼ 165.3 Å
and c¼ 219.2 Å or a¼ 100.2 Å, b¼ 153.5 Å and c¼ 249.2 Å, respectively. Phases
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were determined by molecular replacement using a homology model based on
SceCT (pdb 1od2) as search model in Phaser51,60,61; multicrystal averaging was
applied in density modification. The CT domain was rebuilt and an initial
homology model based on the SceCD structure was fitted into difference density for
CthCD-CTCter1. Iterative cycles of rebuilding and refinement in
Buster converged at Rwork/Rfree of 0.20/0.24. The refined CD fragment served as a
starting model for rebuilding CthCD-CTCter2 at lower resolution. Coordinate
refinement in Buster was additionally guided by reference model restraints and
converged at Rwork/Rfree of 0.24/0.24. Residues 1,114–1,185, 1,213–1,252, 1,380–
1,385, 1,465–1,468 and 2,188–2,195 were disordered in both crystal forms and are
not included in the models. Helical regions C terminal to Glu2264 of both
protomers of CthCD-CTCter1 and C terminal to Leu2259 and Arg2261 of the two
protomers of CthCD-CTCter2, respectively, could not be built unambiguously and
were therefore interpreted by placing poly-alanine stretches. Conservation was
mapped on the CthCD-CTCter1 crystal structure using al2co62 based on a sequence
alignment of 367 fungal ACC sequences calculated by Clustal Omega63. MS
analysis of purified protein detected 7% phosphorylation at Ser1170
(corresponding to Ser1157 in SceCD).
CthCD-CT crystallized in space group P31212 with unit cell constants of
a¼ b¼ 195.0 Å and c¼ 189.5Å and crystals diffracted to a resolution of 7.2 Å. The
structure was solved by molecular replacement using a model composed of CthCT
and CDC2 as search model in Phaser. CDC1 and CDN were placed manually into
the resulting maps, and the model was refined using rigid-body, domain-wise TLS
and B-factor refinement and NCS- and reference model-restrained coordinate
refinement in Buster to Rwork/Rfree of 0.23/0.25. Owing to the low resolution, the
maximum allowed B-factor in Buster refinement was increased from the default
value of 300–500Å2, minimizing B-factor clipping to 5% of all atoms. Residues
1,033–1,035, 1,134–1,152, 1,213–1,252, 1,380–1,385, 1,465–1,468 and 2,188–2,195
were not included in the models. Helical regions C terminal to Leu2259 and
Arg2261 on the two protomers, respectively, were interpreted as described for
CthCD-CTCter. Loop conformations, including the regulatory loop, were modelled
as observed in SceCD. MS analysis of purified protein detected 60%
phosphorylation at Ser1170 (corresponding to Ser1157 in SceCD). Conservation
was mapped on the CthCD-CT crystal structure as for CthCD-CTCter.
CthDBCCP ACC crystallized in space group P6422 with unit cell constants of
a¼ b¼ 462.2 Å and c¼ 204.6 Å, resolution was limited to 8.4 Å. Structure
determination and refinement was performed as for CthCD-CT, with a maximum
allowed B-factor of 500Å2, minimizing B-factor clipping to 3% of all atoms.
Although substantial difference density is observed, no defined positions of the BT
and BC domains could be derived because of disorder or partial in situ
proteolysis or combinations thereof. In addition, residues 1,032–1,039,
1,134–1,152, 1,213–1,252, 1,380–1,385, 1,465–1,468 and 2,188–2,195 were not
included in the model. The MissingAtom macro implemented in Buster was
employed to account for missing atoms, the final Rwork/Rfree were 0.30/0.32. A
region C terminal to Leu2259 on one protomer was interpreted as poly-alanine.
Loop conformations, including the regulatory loop, were modelled as observed in
SceCD. MS analysis of purified protein detected 70% phosphorylation at Ser1170
(corresponding to Ser1157 in SceCD).
Small-angle X-ray scattering. Proteins were thawed on ice and dialysed overnight
against 30mM MOPS pH 7, 200mM ammonium sulfate, 5% glycerol and 10mM
dithiothreitol. Raw scattering data were measured at SAXS beamline B21 at
Diamond Light Source. The samples were measured at concentrations of 2.5, 5 and
10mgml 1. Data were processed using the ATSAS package64 according to
standard procedures65,66. A slight increase in scattering in the very low-resolution
range was observed with increasing protein concentrations, which may be because
of interparticle attraction or minor aggregation. Scattering intensities were thus
extrapolated to zero concentration using point-wise extrapolation implemented in
Primus67. Direct comparison of raw scattering curves demonstrates the similarity
of CthACC and CthDBCCP, and the derived values such as Rg and Porod Volume
match within expected error margins. Molecular mass estimations based on the
SAXS–MOW method68 derive values of 534.7 and 534.0 kDa for CthACC and
CthDBCCP, respectively. The relative discrepancies to the theoretical weights of
516.8 kDa (CthACC) and 503.0 kDa (CthDBCCP) are 3.5% and 6.2%, respectively,
which is in a typical range for this method68.
Electron microscopy. Full-length CthACC was diluted to 0.01mgml 1 in 30mM
MOPS pH 7.0, 200mM ammonium sulfate, 5% glycerol and 10mM dithiothreitol.
Protein sample was adsorbed to a 200-mm copper grid and stained with 2% uranyl
acetate. Grids of CthACC were imaged on a CM-200 microscope (Philips)
equipped with a TVIPS F416 4k CMOS camera (Tietz Video and Image Processing
Systems). The voltage used was 200 kV, and a magnification of  50,000 results in
a pixel size of 2.14Å. Initial image processing and particle picking was carried out
using Xmipp69,70. Overall, 22,309 particles were picked semi-automatically from
236 micrographs with a box size of 300 300 pixels. After extraction, particles with
a z-score of more than three were discarded and 22,257 particles were aligned and
classified into 48 2D class averages using the maximum-likelihood target function
in Fourier space (MLF2D). After 72 iterations, 4,226 additional particles were
discarded and the remaining 18,031 particles were re-aligned and classified into 36
classes using MLF2D with a high-resolution cutoff of 30Å. After 44 iterations the
alignment converged and class averages were extracted.
In vitro biotinylation and activity assay. To ensure full functionality, SceACC
was biotinylated in vitro using the E. coli biotin ligase BirA. The reaction mixture
contained 10mM ACC, 3.7 mM BirA, 50mM Tris-HCl, pH 8, 5.5mM MgCl2,
0.5mM biotin, 60mM NaCl, 3mM ATP and 10% glycerol, and the reaction was
allowed to proceed for 7 h at 30 C.
The catalytic activity of phosphorylated and dephosphorylated SceACC was
measured by following the incorporation of radioactive 14C into acid-stable non-
volatile material40. Dephosphorylated ACC was prepared by overnight treatment
with l protein phosphatase (New England Biolabs) of partially purified ACC before
the final gel filtration step. The removal of the phosphoryl group from Ser1157 was
confirmed by MS. The reaction mixture contained 0.5 mg recombinant ACC in
100mM potassium phosphate, pH 8, 3mM ATP, 5mM MgCl2, 50mM NaH14CO3
(specific activity 7.4MBqmmol 1) and 1mM acetyl-CoA in a total reaction
volume of 100 ml. The reaction mixture was incubated for 15min at 30 C, stopped
by addition of 200 ml 6M HCl and subsequently evaporated to dryness at 85 C.
The non-volatile residue was redissolved in 100 ml of water, 1ml Ultima Gold XR
scintillation medium (Perkin Elmer) was added and the 14C radioactivity was
measured in a Packard Tricarb 2000CA liquid scintillation analyser. Measurements
were carried out in five replicates and catalytic activities were calculated using a
standard curve derived from measurements of varying concentrations of
NaH14CO3 in reaction buffer.
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